TQD MSMS Instrument

Request more information

Complete mass spectrometry solutions for newborn screening

From dried blood spot cards, punchers, instruments, reagents to informatics, PerkinElmer's mass spectrometry solutions empower newborn screening laboratories across the globe to meet their demands. 

TQD MSMS Screening System

TQD MSMS Screening System is the system-level tandem mass spectrometry solution for comprehensive screening of metabolic disorders in neonates. Together with the nonderivatized Neobase kit and dedicated screening software, TQD MSMS Screening System delivers exceptional scan speed and sensitivity, as well as the right tools for easy interpretation of screening results.

TQD MSMS Instrument

WHY CHOOSE our Mass spectrometry solution FOR EXPANDED SCREENING?

With the NeoBase™ non-derivatized kit you can measure amino acids, acylcarnitines and succinylacetone simultaneously
UP TO 40 METABOLIC DISORDERS CAN BE RECOGNIZED FROM A SINGLE DBS SAMPLE
COMBINED PREVALENCE OF ALL DETECTABLE DISORDERS ~1 : 3,000
Product may not be available in all countries. Please check availability with your local PerkinElmer representative.

Expanded screening for metabolic disorders

Optimized products for best results
NeBASE Non-derivatized MSMS kit


More for less - by using the new NeoBase™ non-derivatized method

Our tandem mass spectrometry, derivatized assay allows for the measurement of 30-40 markers to support screening of more than 30 genetic metabolic disorders simultaneously.

For disorders screened with MSMS technology

NeoBase™ Non-derivatized MSMS kit

Is intended for the measurement and evaluation of amino acid, free carnitine and acylcarnite concentrations (the AAAC panel) and succinylacetone from newborn heel prick blood samples dried on filter paper with the non-derivatized method. - View kit

For disorders screened with MSMS technology

NeoBase™ Non-derivatized Assay Solutions

The NeoBase™ Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase Non-derivatized MSMS Kit and the NeoBase Succinylacetone Assay Solution. - View kit

For disorders screened with MSMS technology

NeoBase™ Succinylacetone Assay Solution

The NeoBase™ Succinylacetone Assay Solution is intended for in vitro diagnostic use with the NeoBase Non-derivatized MSMS Kit (3040-0010/3040-001U) and the NeoBase Nonderivatized Assay Solutions (3041-0020). - View kit

For disorders screened with MSMS technology

NeoGram AAAC Tandem Mass Spectrometry kit

The AAAC Multilevel DBS is prepared in whole human blood. The hemoglobin concentration is approximately 170 g/L prior to dispensing onto filter paper, and hematocrit level approximately 50–55%. The product is for maintenance use only. - View kit

For For lysosomal storage disorders (LSD's)

NeoLSD™ MSMS Kit

The first commercial IVD kit for newborn screening of Pompe, MPS-I, Fabry, Gaucher, Niemann-Pick A/B and Krabbe disorders from a single DBS sample. The NeoLSD™ MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-β-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid α glucosidase (GAA), β galactocerebrosidase (GALC), α-galactosidase A (GLA) and α-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies - View kit